Bigbear Pharmaceutical·Medication Guide

• Osimertinib Patient Monitoring

  Osimertinib is a targeted therapy for EGFR-mutant non-small cell lung cancer. During treatment, close monitoring is required for interstitial lung dis···【Read More】

  Update: 2026-07-14Source: Haiou HealthViews: 98

• Serious Side Effects of Osimertinib

  During treatment with Osimertinib, various side effects may occur. If you are unable to determine whether the side effects are serious, please consult···【Read More】

  Update: 2026-07-10Source: Haiou HealthViews: 104

• ​Osimertinib Use in Special Populations

  Osimertinib Use in Special Populations1. Renal Impairment(1) Patients with creatinine clearance (CrCl) between 15 and 89 mL/min: no dose adjustment is···【Read More】

  Update: 2026-07-10Source: Haiou HealthViews: 112

• Indications for Osimertinib

  Osimertinib is commonly used for non-small cell lung cancer (NSCLC). The recommended dose is 80 mg once daily. As individual circumstances vary, the u···【Read More】

  Update: 2026-07-10Source: Haiou HealthViews: 110

• Common Adverse Reactions of Ivosidenib

  Common Adverse Reactions of Ivosidenib1. In patients with acute myeloid leukemia (AML), common adverse reactions (including laboratory abnormalities) ···【Read More】

  Update: 2026-07-10Source: Haiou HealthViews: 106

• Important Safety Information for Ivosidenib

  Patients should take Ivosidenib as prescribed by their physician, and at approximately the same time each day.Important Safety Information for Ivoside···【Read More】

  Update: 2026-07-10Source: Haiou HealthViews: 108

• Management of Adverse Effects of Ivosidenib in Medical Personnel

  Management of Adverse Effects of Ivosidenib in Medical Personnel1. Overall Adverse EventsMost common adverse reactions reported in patients with acute···【Read More】

  Update: 2026-07-10Source: Haiou HealthViews: 108

• Serious side effects of Ivosidenib

  Ivosidenib side effects: What are the side effects of Ivosidenib? During the use of Ivosidenib, some adverse reactions may occur. Patients should pay ···【Read More】

  Update: 2026-07-09Source: Haiou HealthViews: 101

• Ivosidenib Dose Adjustment with Strong CYP3A4 Inhibitors

  Ivosidenib Dose Adjustment with Strong CYP3A4 Inhibitors1.If coadministration is unavoidable:reduce ivosidenib dose to 250 mg once daily.2.After disco···【Read More】

  Update: 2026-07-08Source: Haiou HealthViews: 107

• ​Ivosidenib Use in Special Populations

  Ivosidenib Use in Special Populations1. Renal ImpairmentMild to moderate renal impairment (eGFR ≥30 mL/min/1.73m², MDRD formula): no dose adjustment n···【Read More】

  Update: 2026-07-07Source: Haiou HealthViews: 110

• Ivosidenib Conventional Dosage for Adult Acute Myeloid Leukemia

  Ivosidenib recommended dosage is typically 500 mg once daily. Dosage may vary by indication; always follow physician instructions.Ivosidenib Conventio···【Read More】

  Update: 2026-07-07Source: Haiou HealthViews: 109

• ​Selumetinib Pharmacokinetics

  Selumetinib Pharmacokinetics1. AbsorptionMean absolute bioavailability in adults: 62%.Median time to peak concentration at steady state in pediatric p···【Read More】

  Update: 2026-07-07Source: Haiou HealthViews: 109

• Selumetinib Drug Interactions

  In SPRINT Phase II study Layer 1, adverse reactions reported at an incidence ≥40% in pediatric patients were: vomiting, rash, abdominal pain, diarrhea···【Read More】

  Update: 2026-07-07Source: Haiou HealthViews: 103

• Serious side effects of Selumetinib

  Selumetinib side effects vary in severity; if you encounter any issues, please consult your doctor promptly.Serious side effects of SelumetinibDuring ···【Read More】

  Update: 2026-07-07Source: Haiou HealthViews: 106

• Selumetinib Drug Interaction Dose Adjustment

  Selumetinib Drug Interaction Dose AdjustmentCo-administration with Strong/Moderate CYP3A4 Inhibitors or FluconazolePrinciple: Avoid concomitant use wh···【Read More】

  Update: 2026-07-07Source: Haiou HealthViews: 111